Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference | ||||||
By: GlobeNewswire - 20 Feb 2024 | Back to overview list |
|||||
CUPERTINO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the 2024 BIO CEO & Investor Conference, taking place February 26-27, 2024, in New York, NY.
To register for the conference and schedule a one-on-one meeting with Reviva management, please use the link HERE. About Reviva Corporate Contact: Investor Relations Contact: Media Contact: |
||||||
|
||||||
Copyright 2024 GlobeNewswire | Back to overview list |